Hypoxia-regulated microRNAs in human cancer

Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that cont...

Full description

Saved in:
Bibliographic Details
Published inActa pharmacologica Sinica Vol. 34; no. 3; pp. 336 - 341
Main Authors Shen, Guomin, Li, Xiaobo, Jia, Yong-feng, Piazza, Gary A, Xi, Yaguang
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2013
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1671-4083
1745-7254
1745-7254
DOI10.1038/aps.2012.195

Cover

Abstract Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIFI. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvi- ronments and thus benefit the development of new anticancer drugs.
AbstractList Hypoxia plays an important role in the tumor microenvironment by allowing the development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIF1. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvironments and thus benefit the development of new anticancer drugs.Hypoxia plays an important role in the tumor microenvironment by allowing the development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIF1. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvironments and thus benefit the development of new anticancer drugs.
Hypoxia plays an important role in the tumor microenvironment by allowing the development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIF1. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvironments and thus benefit the development of new anticancer drugs.
Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIFI. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvi- ronments and thus benefit the development of new anticancer drugs.
Author Guomin SHEN Xiaobo LI Yong-feng JIA Gary A PIAZZA Yaguang XI
AuthorAffiliation Mitchell Cancer Institute, University of South Alabama, Alabama, USA Inner Mongolia Medical University, Hohhot 010021, China
Author_xml – sequence: 1
  givenname: Guomin
  surname: Shen
  fullname: Shen, Guomin
  organization: Mitchell Cancer Institute, University of South Alabama
– sequence: 2
  givenname: Xiaobo
  surname: Li
  fullname: Li, Xiaobo
  organization: Mitchell Cancer Institute, University of South Alabama
– sequence: 3
  givenname: Yong-feng
  surname: Jia
  fullname: Jia, Yong-feng
  organization: Inner Mongolia Medical University
– sequence: 4
  givenname: Gary A
  surname: Piazza
  fullname: Piazza, Gary A
  organization: Mitchell Cancer Institute, University of South Alabama
– sequence: 5
  givenname: Yaguang
  surname: Xi
  fullname: Xi, Yaguang
  email: xi@usouthal.edu
  organization: Mitchell Cancer Institute, University of South Alabama
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23377548$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtLAzEURoMovneupeJG0Kl5TpKNIOILREF0HdI000ZmkprMiP57U_tARVcJ5NzDl_ttgVUfvAVgD8E-gkSc6knqY4hwH0m2AjYRp6zgmNHVfC85KigUZANspfQCIcEEyXWwgQnhnFGxCY5vPibh3eki2lFX69YOe40zMTzen6ee871x12jfM9obG3fAWqXrZHfn5zZ4vrp8urgp7h6uby_O7wrDKG4LJIiuBDakgkPDS4spQxIJSoXWXEhLtYUMClpWlmBc0bKUFUcDLcgA0oGpyDY4m3kn3aCxQ2N9G3WtJtE1On6ooJ36-eLdWI3CmyJMcInKLDiaC2J47WxqVeOSsXWtvQ1dUoggKiQuIc_o4S_0JXTR5-99UQxxyKbC_e-JllEWe8wAngF5dSlFWynjWt26MA3oaoWgmpalcllqWpbKZeWhk19DC-8_eDHDU8b8yMZvUf_mD-b6cfCj1zyy9FNGqOQSkk9tVq47
CitedBy_id crossref_primary_10_1158_1078_0432_CCR_15_0737
crossref_primary_10_1186_s13046_020_01613_y
crossref_primary_10_1371_journal_pone_0141565
crossref_primary_10_1016_j_biopha_2024_116165
crossref_primary_10_1155_2016_5728438
crossref_primary_10_3390_cimb46110741
crossref_primary_10_1016_j_canlet_2016_04_011
crossref_primary_10_3390_cells11010012
crossref_primary_10_1111_cas_13791
crossref_primary_10_1007_s12094_020_02513_5
crossref_primary_10_20517_evcna_2023_52
crossref_primary_10_1152_physrev_00029_2015
crossref_primary_10_18632_genesandcancer_69
crossref_primary_10_1093_carcin_bgw050
crossref_primary_10_1016_j_gene_2019_05_038
crossref_primary_10_1186_s12943_017_0603_1
crossref_primary_10_1007_s12038_018_9789_7
crossref_primary_10_1186_s13046_018_0764_9
crossref_primary_10_3892_ijo_2015_3007
crossref_primary_10_1016_j_critrevonc_2020_103196
crossref_primary_10_1155_2020_3929435
crossref_primary_10_2217_fon_14_201
crossref_primary_10_1038_s41598_020_78242_0
crossref_primary_10_3389_fgene_2021_662468
crossref_primary_10_1016_j_gene_2017_08_006
crossref_primary_10_3390_metabo13040543
crossref_primary_10_1016_j_bioactmat_2022_07_004
crossref_primary_10_1186_s13046_020_1535_y
crossref_primary_10_1097_ALN_0000000000000969
crossref_primary_10_3892_ijmm_2014_1661
crossref_primary_10_3892_ijmm_2018_4003
crossref_primary_10_1002_path_5187
crossref_primary_10_1016_j_gene_2013_07_064
crossref_primary_10_1016_j_cca_2025_120215
crossref_primary_10_1002_jcb_25059
crossref_primary_10_3390_ijms21176083
crossref_primary_10_1016_j_jare_2021_10_007
crossref_primary_10_1186_s12929_020_00658_7
crossref_primary_10_3892_or_2017_5708
crossref_primary_10_1016_j_lfs_2025_123569
crossref_primary_10_5507_bp_2015_025
crossref_primary_10_1113_JP280572
crossref_primary_10_1038_s41388_024_03129_7
crossref_primary_10_1038_srep35316
crossref_primary_10_1016_j_drudis_2018_05_003
crossref_primary_10_1007_s10695_021_01017_5
crossref_primary_10_1016_j_semcancer_2020_09_002
crossref_primary_10_1016_j_lfs_2015_07_002
crossref_primary_10_1016_j_omto_2021_06_015
crossref_primary_10_1016_j_canlet_2020_06_024
crossref_primary_10_1038_s41416_021_01326_9
crossref_primary_10_18632_oncotarget_3604
crossref_primary_10_1016_j_mam_2016_01_003
crossref_primary_10_3892_ijo_2018_4285
crossref_primary_10_18632_aging_202542
crossref_primary_10_3390_ijms19113378
crossref_primary_10_1080_10409238_2022_2088684
crossref_primary_10_1371_journal_pone_0080844
crossref_primary_10_1016_j_bbcan_2015_02_001
crossref_primary_10_3892_ijo_2015_3056
crossref_primary_10_1038_s41598_020_60935_1
crossref_primary_10_1155_2024_9347381
crossref_primary_10_1016_j_febslet_2014_05_067
crossref_primary_10_1371_journal_pone_0113050
crossref_primary_10_1177_1535370215610442
crossref_primary_10_1371_journal_pcbi_1004217
crossref_primary_10_3390_jcm8020130
crossref_primary_10_1186_s12935_023_03086_3
crossref_primary_10_3390_jcm13247644
crossref_primary_10_1186_1471_2164_15_686
crossref_primary_10_3389_fonc_2019_01404
crossref_primary_10_1016_j_yexmp_2020_104592
crossref_primary_10_3724_abbs_2023231
crossref_primary_10_1038_s41598_022_12566_x
crossref_primary_10_1186_s12885_017_3140_9
crossref_primary_10_1007_s00432_019_02940_0
crossref_primary_10_1186_s12885_021_08978_z
crossref_primary_10_1016_j_omtn_2019_09_002
crossref_primary_10_24075_brsmu_2020_074
crossref_primary_10_3892_ol_2015_3344
crossref_primary_10_3390_cells10123311
crossref_primary_10_3390_ijms24043496
crossref_primary_10_3389_fonc_2021_708765
crossref_primary_10_3390_biom12050686
crossref_primary_10_1158_1940_6207_CAPR_13_0032
crossref_primary_10_3390_antiox13111326
crossref_primary_10_1021_es504676s
crossref_primary_10_1634_theoncologist_2019_0497
crossref_primary_10_3389_fcell_2019_00004
crossref_primary_10_3389_fimmu_2022_913951
crossref_primary_10_1111_1346_8138_12314
crossref_primary_10_1016_j_envpol_2020_115597
crossref_primary_10_3171_2015_8_JNS15437
crossref_primary_10_1186_1471_2407_14_429
crossref_primary_10_1016_j_canlet_2019_02_030
crossref_primary_10_1002_gcc_22244
crossref_primary_10_1186_s13046_020_01824_3
crossref_primary_10_1080_20013078_2019_1567219
crossref_primary_10_1080_07357907_2016_1245317
crossref_primary_10_47529_2223_2524_2023_4_8
crossref_primary_10_1002_wrna_1820
crossref_primary_10_1016_j_genrep_2021_101408
crossref_primary_10_3389_fonc_2021_683725
crossref_primary_10_1155_2024_5523283
crossref_primary_10_1080_08941939_2016_1206999
crossref_primary_10_1038_cmi_2014_45
crossref_primary_10_3389_fphar_2020_00013
crossref_primary_10_1371_journal_pone_0164976
crossref_primary_10_1186_s12903_022_02425_6
crossref_primary_10_1016_j_intimp_2022_109040
crossref_primary_10_3390_cells9122598
crossref_primary_10_3389_fphar_2022_844104
crossref_primary_10_3892_ol_2017_7636
crossref_primary_10_1002_wrna_1676
crossref_primary_10_1111_cpr_12264
crossref_primary_10_3390_ijms20194799
crossref_primary_10_1002_jcp_26347
crossref_primary_10_18632_oncotarget_11772
crossref_primary_10_3390_genes16020140
crossref_primary_10_3389_fphar_2022_860898
crossref_primary_10_1038_onc_2014_254
Cites_doi 10.1093/bioinformatics/btr180
10.1158/0008-5472.CAN-12-0667
10.1038/nature03677
10.1128/MCB.16.9.4604
10.1016/j.ccr.2007.04.001
10.1038/nrc909
10.4161/cbt.7.2.5297
10.1038/emboj.2009.214
10.1161/01.RES.0000102937.50486.1B
10.1038/onc.2010.23
10.1158/0008-5472.CAN-11-0365
10.1128/MCB.05776-11
10.1371/journal.pone.0037537
10.1016/S0076-6879(04)81023-1
10.4161/cc.9.6.11006
10.1038/onc.2011.655
10.1371/journal.pone.0017167
10.2217/14796694.1.6.779
10.1371/journal.pone.0007629
10.1128/MCB.01242-10
10.1186/bcr2720
10.1074/jbc.M110.109207
10.1074/jbc.M111.284158
10.1158/0008-5472.CAN-08-2516
10.1074/jbc.M110.158790
10.1038/nbt.1618
10.1172/JCI42980
10.1038/cdd.2010.119
10.1371/journal.pone.0019139
10.1074/jbc.M109.020925
10.1016/S1471-4914(02)02317-1
10.4161/cc.8.17.9387
10.1007/s00424-010-0910-5
10.1046/j.1432-1033.2003.03846.x
10.1186/1741-7015-8-64
10.1016/j.molmed.2010.03.004
10.1016/j.yexcr.2012.02.010
10.1002/hep.24614
10.1074/jbc.M109.052779
10.1038/onc.2010.193
10.1158/0008-5472.CAN-12-1383
10.1093/bioinformatics/btp655
10.1016/j.cmet.2009.05.005
10.1002/jcp.21558
10.1016/j.cmet.2009.08.015
10.1128/MCB.01395-06
10.1038/ncb1691
10.1073/pnas.0911082107
10.1074/jbc.M800731200
10.1158/0008-5472.CAN-10-3320
10.1074/jbc.C600252200
10.1158/0008-5472.CAN-07-6460
10.1111/j.1440-1746.2007.04997.x
10.1371/journal.pone.0010345
10.1128/MCB.01276-10
10.1038/nm1075
10.1056/NEJMra0706596
10.1111/j.1582-4934.2011.01484.x
10.1161/CIRCRESAHA.108.193102
10.1016/j.molcel.2009.09.006
10.1038/74651
10.1093/cvr/cvq082
10.1158/0008-5472.CAN-09-2448
10.1002/jcp.22126
ContentType Journal Article
Copyright The Author(s) 2013
Copyright Nature Publishing Group Mar 2013
Copyright © 2013 CPS and SIMM 2013 CPS and SIMM
Copyright_xml – notice: The Author(s) 2013
– notice: Copyright Nature Publishing Group Mar 2013
– notice: Copyright © 2013 CPS and SIMM 2013 CPS and SIMM
DBID 2RA
92L
CQIGP
W91
~WA
C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7QR
7T5
7TK
7TO
7U9
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/aps.2012.195
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
ProQuest Central Student

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals (WRLC)
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Hypoxia-regulated microRNAs in human cancer
EISSN 1745-7254
EndPage 341
ExternalDocumentID PMC3587916
2907523331
23377548
10_1038_aps_2012_195
45349790
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R21 CA160280
– fundername: NCI NIH HHS
  grantid: 1R21CA160280-01A1
GroupedDBID ---
-05
-0E
-Q-
-S~
.3N
0R~
188
1OC
23M
2RA
2WC
31~
36B
3V.
4.4
406
53G
5GY
5VR
5VS
6J9
70F
7X7
8-1
88E
8FI
8FJ
8R4
8R5
8RM
92L
92M
9D9
9DE
A8Z
AADWK
AANZL
AATNV
AAWBL
AAYFA
AAYJO
AAZLF
ABAWZ
ABGIJ
ABKZE
ABUWG
ACAOD
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACIGE
ACIWK
ACKTT
ACPRK
ACRQY
ACTTH
ACVWB
ACXQS
ACZOJ
ADBBV
ADFRT
ADHDB
ADMDM
ADQMX
ADRAZ
ADYYL
AEDAW
AEFTE
AEJRE
AENEX
AESKC
AEVLU
AEXYK
AFBPY
AFKRA
AFNRJ
AFRAH
AFSHS
AFUIB
AFZJQ
AGAYW
AGEZK
AGGBP
AGHAI
AHMBA
AHSBF
AILAN
AJAOE
AJCLW
AJDOV
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMRJV
AMYLF
AOIJS
AXYYD
BAWUL
BBNVY
BENPR
BFHJK
BHPHI
BKKNO
BPHCQ
BVXVI
C1A
CAG
CAJEE
CAJUS
CCEZO
CCPQU
CHBEP
CIEJG
CO8
COF
CQIGP
CS3
CW9
DIK
DNIVK
DPUIP
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
ESTFP
F5P
FA0
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HH5
HMCUK
HYE
HZI
HZ~
IWAJR
JSO
JUIAU
JZLTJ
K97
KQ8
LH4
LW6
M1P
M48
M7P
MK0
NQJWS
NXXTH
NYICJ
O9-
OK1
OVD
P2P
P6G
PQQKQ
PROAC
PSQYO
Q--
Q-4
Q2X
R-E
RNT
RNTTT
RPM
RT5
S..
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
T8U
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
U1F
U1G
U5E
U5O
UKHRP
UZ5
W91
~88
~NG
~WA
-SE
AACDK
AASML
AAXDM
ABAKF
ABZZP
ACMJI
AEFQL
AEMSY
AFBBN
AGQEE
AIGIU
ALIPV
C6C
FIGPU
LGEZI
LOTEE
NADUK
ROL
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
SOJ
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7QP
7QR
7T5
7TK
7TO
7U9
7XB
8FD
8FE
8FH
8FK
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
LK8
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c542t-183af82c3f0dc76e2451918448aa789e4ae050846fe322f4669f71ba83b04bcf3
IEDL.DBID M48
ISSN 1671-4083
1745-7254
IngestDate Thu Aug 21 17:32:45 EDT 2025
Thu Sep 04 16:08:13 EDT 2025
Fri Jul 25 08:58:00 EDT 2025
Mon Jul 21 06:00:57 EDT 2025
Tue Jul 01 02:04:11 EDT 2025
Thu Apr 24 22:57:21 EDT 2025
Fri Feb 21 02:38:48 EST 2025
Wed Feb 14 11:03:29 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords hypoxia
chemoresistance
human cancer
cell cycle
angiogenesis
microRNA
apoptosis
HIF1
radioresistance
cancer metastasis
Language English
License https://creativecommons.org/licenses/by-nc-nd/3.0
This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c542t-183af82c3f0dc76e2451918448aa789e4ae050846fe322f4669f71ba83b04bcf3
Notes microRNA; hypoxia; HIF1; human cancer; angiogenesis; apoptosis; cell cycle; cancer metastasis; chemoresistance; radiore-sistance
Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIFI. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvi- ronments and thus benefit the development of new anticancer drugs.
31-1347/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/aps.2012.195
PMID 23377548
PQID 1314517056
PQPubID 28815
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3587916
proquest_miscellaneous_1314892607
proquest_journals_1314517056
pubmed_primary_23377548
crossref_citationtrail_10_1038_aps_2012_195
crossref_primary_10_1038_aps_2012_195
springer_journals_10_1038_aps_2012_195
chongqing_primary_45349790
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-03-01
PublicationDateYYYYMMDD 2013-03-01
PublicationDate_xml – month: 03
  year: 2013
  text: 2013-03-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
– name: Shanghai
PublicationTitle Acta pharmacologica Sinica
PublicationTitleAbbrev Acta Pharmacol Sin
PublicationTitleAlternate Acta Pharmacologica Sinica
PublicationYear 2013
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Chen, Lin, Chung, Lang, Lin, Huang (CR61) 2012; 72
Kulshreshtha, Ferracin, Wojcik, Garzon, Alder, Agosto-Perez (CR22) 2007; 27
Zhang, Gao, Fukuda, Kumar, Krishnamachary, Zeller (CR49) 2007; 11
Li, Gao, Cui, Gary, Dyess, Taylor (CR26) 2012; 31
Kim, Haider, Jiang, Ashraf (CR56) 2009; 284
Wu, Xie, Chen (CR62) 2007; 22
Zhu, Chen, Luo, Guan, Zhang, Zhang (CR64) 2005; 24
Chen, Li, Zhang, Huang, Luthra (CR53) 2010; 29
Haque, Banerjee, Mehta, De, Majumder, Mayo (CR8) 2011; 286
Taguchi, Yanagisawa, Tanaka, Cao, Matsuyama, Goto (CR35) 2008; 68
Chan, Loscalzo (CR15) 2010; 9
Ying, Liang, Guo, Zha, Tian, Huang (CR60) 2011; 54
Zhang, Sun, Dai, Walsh, Imakura, Schelter (CR59) 2009; 8
Ferrara (CR40) 2002; 2
Cha, Chen, Johansson, Chu, Wang, Jeng (CR37) 2010; 70
Carmeliet (CR39) 2000; 6
Pocock (CR4) 2011; 461
Ma, Reinhardt, Pan, Soutschek, Bhat, Marcusson (CR28) 2010; 28
Yamakuchi, Lotterman, Bao, Hruban, Karim, Mendell (CR38) 2010; 107
Wang, Wang, Howell, Qian, Huang, Riker (CR17) 2010; 26
Ma (CR27) 2010; 12
Kerbel (CR41) 2008; 358
Vaupel, Mayer, Hockel (CR2) 2004; 381
Bruning, Cerone, Neufeld, Fitzpatrick, Cheong, Scholz (CR6) 2011; 31
Semenza (CR3) 2002; 8
Forsythe, Jiang, Iyer, Agani, Leung, Koos (CR42) 1996; 16
Cascio, D'Andrea, Ferla, Surmacz, Gulotta, Amodeo (CR47) 2010; 224
Crosby, Kulshreshtha, Ivan, Glazer (CR7) 2009; 69
Neal, Michael, Rawlings, Van der Hoek, Gleadle (CR10) 2010; 8
Wang, Howel, Bruheim, Ju, Owen, Fodstad (CR16) 2011; 6
Giannakakis, Sandaltzopoulos, Greshock, Liang, Huang, Hasegawa (CR54) 2008; 7
Cheng, Zhu, Yang, Liu, Dong, Wang (CR57) 2010; 87
Simon, Tournaire, Pouyssegur (CR43) 2008; 217
Yang, Sun, Cao, Liu, Tian, Zhu (CR65) 2012; 318
De Milito, Fais (CR63) 2005; 1
Huang, Le, Giaccia (CR14) 2010; 16
Zhang, Shen, Liu, Wang, Zhao, Zhang (CR25) 2012; 16
Yang, Wu, Chiou, Chen, Chang, Liu (CR23) 2008; 10
Kelly, Hackett, Hirota, Oshima, Cai, Berg-Dixon (CR45) 2003; 93
Fasanaro, D'Alessandra, Di Stefano, Melchionna, Romani, Pompilio (CR46) 2008; 283
Krishnan, Suter, Windak, Krebs, Felley, Montessuit (CR24) 2009; 9
Puissegur, Mazure, Bertero, Pradelli, Grosso, Robbe-Sermesant (CR55) 2011; 18
Liu, Li, Chen, Jing, Carpenter, Jiang (CR48) 2011; 6
Fasanaro, Greco, Lorenzi, Pescatori, Brioschi, Kulshreshtha (CR51) 2009; 284
Sayed, He, Hong, Gao, Rane, Yang (CR58) 2010; 285
Yan, Xue, Mei, Wang, Ding, Liu (CR29) 2009; 28
Mathieu, Zhang, Zhou, Wang, Heddleston, Pinna (CR9) 2011; 71
Wang, Zhang, Wang, Tan, Xi (CR19) 2012; 7
Hofbauer, Gess, Lohaus, Meyer, Katschinski, Kurtz (CR32) 2003; 270
Noman, Buart, Romero, Ketari, Janji, Mari (CR1) 2012; 72
Chan, Zhang, Hemann, Mahoney, Zweier, Loscalzo (CR50) 2009; 10
Lei, Li, Yang, Fang, Zhang, Feng (CR13) 2009; 4
Ceradini, Kulkarni, Callaghan, Tepper, Bastidas, Kleinman (CR44) 2004; 10
Chan, Khanna, Roy, Sen (CR12) 2011; 286
Wang, Wang, Xi (CR18) 2011; 27
Rane, He, Sayed, Vashistha, Malhotra, Sadoshima (CR36) 2009; 104
Woods, Thomson, Hammond (CR21) 2007; 282
Kelly, Souza, Clish, Puigserver (CR33) 2011; 31
Polytarchou, Iliopoulos, Hatziapostolou, Kottakis, Maroulakou, Struhl (CR30) 2011; 71
Favaro, Ramachandran, McCormick, Gee, Blancher, Crosby (CR52) 2010; 5
Loayza-Puch, Yoshida, Matsuzaki, Takahashi, Kitayama, Noda (CR11) 2010; 29
Ghosh, Subramanian, Adhikari, Zhang, Joshi, Basi (CR34) 2010; 120
O'Donnell, Wentzel, Zeller, Dang, Mendell (CR20) 2005; 435
Wu, So, Davis-Dusenbery, Qi, Bloch, Shi (CR31) 2011; 31
Huang, Ding, Bennewith, Tong, Welford, Ang (CR5) 2009; 35
W Yang (BFaps2012195_CR65) 2012; 318
R Kulshreshtha (BFaps2012195_CR22) 2007; 27
SY Chan (BFaps2012195_CR15) 2010; 9
B Wang (BFaps2012195_CR17) 2010; 26
H Zhang (BFaps2012195_CR49) 2007; 11
TJ Kelly (BFaps2012195_CR33) 2011; 31
YC Chan (BFaps2012195_CR12) 2011; 286
S Rane (BFaps2012195_CR36) 2009; 104
P Carmeliet (BFaps2012195_CR39) 2000; 6
N Ferrara (BFaps2012195_CR40) 2002; 2
X Li (BFaps2012195_CR26) 2012; 31
A De Milito (BFaps2012195_CR63) 2005; 1
MZ Noman (BFaps2012195_CR1) 2012; 72
S Cascio (BFaps2012195_CR47) 2010; 224
R Pocock (BFaps2012195_CR4) 2011; 461
X Huang (BFaps2012195_CR14) 2010; 16
HY Chen (BFaps2012195_CR61) 2012; 72
B Wang (BFaps2012195_CR16) 2011; 6
M Yamakuchi (BFaps2012195_CR38) 2010; 107
E Favaro (BFaps2012195_CR52) 2010; 5
KH Hofbauer (BFaps2012195_CR32) 2003; 270
MP Puissegur (BFaps2012195_CR55) 2011; 18
U Bruning (BFaps2012195_CR6) 2011; 31
LZ Liu (BFaps2012195_CR48) 2011; 6
ME Crosby (BFaps2012195_CR7) 2009; 69
G Ghosh (BFaps2012195_CR34) 2010; 120
KA O'Donnell (BFaps2012195_CR20) 2005; 435
L Ma (BFaps2012195_CR27) 2010; 12
FL Zhang (BFaps2012195_CR25) 2012; 16
P Vaupel (BFaps2012195_CR2) 2004; 381
B Wang (BFaps2012195_CR19) 2012; 7
ST Cha (BFaps2012195_CR37) 2010; 70
HW Kim (BFaps2012195_CR56) 2009; 284
I Haque (BFaps2012195_CR8) 2011; 286
Z Lei (BFaps2012195_CR13) 2009; 4
Z Zhang (BFaps2012195_CR59) 2009; 8
P Fasanaro (BFaps2012195_CR46) 2008; 283
A Taguchi (BFaps2012195_CR35) 2008; 68
C Wu (BFaps2012195_CR31) 2011; 31
MP Simon (BFaps2012195_CR43) 2008; 217
C Polytarchou (BFaps2012195_CR30) 2011; 71
Z Chen (BFaps2012195_CR53) 2010; 29
B Wang (BFaps2012195_CR18) 2011; 27
DJ Ceradini (BFaps2012195_CR44) 2004; 10
F Loayza-Puch (BFaps2012195_CR11) 2010; 29
J Mathieu (BFaps2012195_CR9) 2011; 71
H Zhu (BFaps2012195_CR64) 2005; 24
RS Kerbel (BFaps2012195_CR41) 2008; 358
MH Yang (BFaps2012195_CR23) 2008; 10
CS Neal (BFaps2012195_CR10) 2010; 8
GL Semenza (BFaps2012195_CR3) 2002; 8
L Ma (BFaps2012195_CR28) 2010; 28
BD Kelly (BFaps2012195_CR45) 2003; 93
Q Ying (BFaps2012195_CR60) 2011; 54
A Giannakakis (BFaps2012195_CR54) 2008; 7
HL Yan (BFaps2012195_CR29) 2009; 28
P Fasanaro (BFaps2012195_CR51) 2009; 284
K Woods (BFaps2012195_CR21) 2007; 282
SY Chan (BFaps2012195_CR50) 2009; 10
Y Cheng (BFaps2012195_CR57) 2010; 87
XZ Wu (BFaps2012195_CR62) 2007; 22
JA Forsythe (BFaps2012195_CR42) 1996; 16
D Sayed (BFaps2012195_CR58) 2010; 285
J Krishnan (BFaps2012195_CR24) 2009; 9
X Huang (BFaps2012195_CR5) 2009; 35
18463380 - N Engl J Med. 2008 May 8;358(19):2039-49
20219857 - Cardiovasc Res. 2010 Aug 1;87(3):431-9
18297062 - Nat Cell Biol. 2008 Mar;10(3):295-305
22286762 - Oncogene. 2012 Nov 29;31(48):4979-86
20434954 - Trends Mol Med. 2010 May;16(5):230-7
17482131 - Cancer Cell. 2007 May;11(5):407-20
22144109 - Hepatology. 2011 Dec;54(6):2064-75
14622280 - Eur J Biochem. 2003 Nov;270(22):4515-22
17194750 - Mol Cell Biol. 2007 Mar;27(5):1859-67
18059191 - Cancer Biol Ther. 2008 Feb;7(2):255-64
20308559 - Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9
21555366 - Cancer Res. 2011 Jul 1;71(13):4720-31
21544242 - PLoS One. 2011;6(4):e19139
19265035 - Circ Res. 2009 Apr 10;104(7):879-86
20232316 - J Cell Physiol. 2010 Jul;224(1):242-9
21807897 - Mol Cell Biol. 2011 Oct;31(19):4087-96
20972335 - J Clin Invest. 2010 Nov;120(11):4141-54
21969601 - Mol Cell Biol. 2011 Dec;31(23):4760-74
21081489 - J Biol Chem. 2011 Jan 21;286(3):2047-56
22962263 - Cancer Res. 2012 Sep 15;72(18):4629-41
17559361 - J Gastroenterol Hepatol. 2007 Aug;22(8):1178-82
20964835 - BMC Med. 2010;8:64
20351690 - Nat Biotechnol. 2010 Apr;28(4):341-7
18720385 - J Cell Physiol. 2008 Dec;217(3):809-18
20237418 - Cell Cycle. 2010 Mar 15;9(6):1072-83
15063685 - Methods Enzymol. 2004;381:335-54
15944709 - Nature. 2005 Jun 9;435(7043):839-43
19721136 - J Biol Chem. 2009 Nov 27;284(48):33161-8
8756616 - Mol Cell Biol. 1996 Sep;16(9):4604-13
19652553 - Cell Cycle. 2009 Sep 1;8(17):2756-68
16471319 - J Exp Clin Cancer Res. 2005 Dec;24(4):565-74
19933824 - Bioinformatics. 2010 Jan 15;26(2):228-34
22050843 - J Cell Mol Med. 2012 Aug;16(8):1889-99
15235597 - Nat Med. 2004 Aug;10(8):858-64
21712410 - Cancer Res. 2011 Jul 1;71(13):4640-52
19141645 - Cancer Res. 2009 Feb 1;69(3):1221-9
22655055 - PLoS One. 2012;7(5):e37537
19782034 - Mol Cell. 2009 Sep 24;35(6):856-67
20154725 - Oncogene. 2010 May 6;29(18):2638-48
21207057 - Pflugers Arch. 2011 Mar;461(3):307-15
14576200 - Circ Res. 2003 Nov 28;93(11):1074-81
19808020 - Cell Metab. 2009 Oct;10(4):273-84
21067538 - Breast Cancer Res. 2010;12(5):210
22593189 - Cancer Res. 2012 Jul 15;72(14):3631-41
10742145 - Nat Med. 2000 Apr;6(4):389-95
19490906 - Cell Metab. 2009 Jun;9(6):512-24
19826008 - J Biol Chem. 2009 Dec 11;284(50):35134-43
22020939 - J Biol Chem. 2011 Dec 16;286(50):43475-85
18632605 - Cancer Res. 2008 Jul 15;68(14):5540-5
12360282 - Nat Rev Cancer. 2002 Oct;2(10):795-803
11927290 - Trends Mol Med. 2002;8(4 Suppl):S62-7
21498399 - Bioinformatics. 2011 Jun 1;27(11):1506-12
19893619 - PLoS One. 2009;4(10):e7629
20498629 - Oncogene. 2010 Jul 29;29(30):4362-8
18417479 - J Biol Chem. 2008 Jun 6;283(23):15878-83
20436681 - PLoS One. 2010;5(4):e10345
17135268 - J Biol Chem. 2007 Jan 26;282(4):2130-4
20885442 - Cell Death Differ. 2011 Mar;18(3):465-78
20404348 - J Biol Chem. 2010 Jun 25;285(26):20281-90
21347261 - PLoS One. 2011;6(2):e17167
22387901 - Exp Cell Res. 2012 May 1;318(8):944-54
16556057 - Future Oncol. 2005 Dec;1(6):779-86
21555452 - Mol Cell Biol. 2011 Jul;31(13):2696-706
19696742 - EMBO J. 2009 Sep 16;28(18):2719-32
20233879 - Cancer Res. 2010 Apr 1;70(7):2675-85
References_xml – volume: 27
  start-page: 1506
  year: 2011
  end-page: 12
  ident: CR18
  article-title: Normalizing bead-based microRNA expression data: a measurement error model-based approach
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btr180
– volume: 72
  start-page: 3631
  year: 2012
  end-page: 41
  ident: CR61
  article-title: miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-0667
– volume: 435
  start-page: 839
  year: 2005
  end-page: 43
  ident: CR20
  article-title: c-Myc-regulated microRNAs modulate E2F1 expression
  publication-title: Nature
  doi: 10.1038/nature03677
– volume: 16
  start-page: 4604
  year: 1996
  end-page: 13
  ident: CR42
  article-title: Activation of vascular endothelial growth factor gene transcription by hypoxia–inducible factor 1
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.16.9.4604
– volume: 11
  start-page: 407
  year: 2007
  end-page: 20
  ident: CR49
  article-title: HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.04.001
– volume: 2
  start-page: 795
  year: 2002
  end-page: 803
  ident: CR40
  article-title: VEGF and the quest for tumour angiogenesis factors
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc909
– volume: 7
  start-page: 255
  year: 2008
  end-page: 64
  ident: CR54
  article-title: miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.7.2.5297
– volume: 28
  start-page: 2719
  year: 2009
  end-page: 32
  ident: CR29
  article-title: Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis
  publication-title: EMBO J
  doi: 10.1038/emboj.2009.214
– volume: 93
  start-page: 1074
  year: 2003
  end-page: 81
  ident: CR45
  article-title: Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000102937.50486.1B
– volume: 29
  start-page: 2638
  year: 2010
  end-page: 48
  ident: CR11
  article-title: Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs
  publication-title: Oncogene
  doi: 10.1038/onc.2010.23
– volume: 71
  start-page: 4720
  year: 2011
  end-page: 31
  ident: CR30
  article-title: Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-0365
– volume: 31
  start-page: 4760
  year: 2011
  end-page: 74
  ident: CR31
  article-title: Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.05776-11
– volume: 7
  start-page: e37537
  year: 2012
  ident: CR19
  article-title: Testing for differentially-expressed microRNAs with errors-in-variables nonparametric regression
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0037537
– volume: 381
  start-page: 335
  year: 2004
  end-page: 54
  ident: CR2
  article-title: Tumor hypoxia and malignant progression
  publication-title: Methods Enzymol
  doi: 10.1016/S0076-6879(04)81023-1
– volume: 9
  start-page: 1072
  year: 2010
  end-page: 83
  ident: CR15
  article-title: MicroRNA-210: a unique and pleiotropic hypoxamir
  publication-title: Cell Cycle
  doi: 10.4161/cc.9.6.11006
– volume: 31
  start-page: 4979
  year: 2012
  end-page: 86
  ident: CR26
  article-title: Sulindac inhibits tumor cell invasion by suppressing NF-kappaB-mediated transcription of microRNAs
  publication-title: Oncogene
  doi: 10.1038/onc.2011.655
– volume: 6
  start-page: e17167
  year: 2011
  ident: CR16
  article-title: Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0017167
– volume: 1
  start-page: 779
  year: 2005
  end-page: 86
  ident: CR63
  article-title: Tumor acidity, chemoresistance and proton pump inhibitors
  publication-title: Future Oncol
  doi: 10.2217/14796694.1.6.779
– volume: 4
  start-page: e7629
  year: 2009
  ident: CR13
  article-title: Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0007629
– volume: 31
  start-page: 2696
  year: 2011
  end-page: 706
  ident: CR33
  article-title: A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01242-10
– volume: 12
  start-page: 210
  year: 2010
  ident: CR27
  article-title: Role of miR-10b in breast cancer metastasis
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr2720
– volume: 285
  start-page: 20281
  year: 2010
  end-page: 90
  ident: CR58
  article-title: MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.109207
– volume: 286
  start-page: 43475
  year: 2011
  end-page: 85
  ident: CR8
  article-title: Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1alpha-TWIST signaling networks in human breast cancer cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.284158
– volume: 69
  start-page: 1221
  year: 2009
  end-page: 9
  ident: CR7
  article-title: MicroRNA regulation of DNA repair gene expression in hypoxic stress
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-2516
– volume: 286
  start-page: 2047
  year: 2011
  end-page: 56
  ident: CR12
  article-title: miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.158790
– volume: 28
  start-page: 341
  year: 2010
  end-page: 7
  ident: CR28
  article-title: Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
  publication-title: Nature Biotechnol
  doi: 10.1038/nbt.1618
– volume: 120
  start-page: 4141
  year: 2010
  end-page: 54
  ident: CR34
  article-title: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis
  publication-title: J Clin Invest
  doi: 10.1172/JCI42980
– volume: 18
  start-page: 465
  year: 2011
  end-page: 78
  ident: CR55
  article-title: miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2010.119
– volume: 6
  start-page: e19139
  year: 2011
  ident: CR48
  article-title: MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019139
– volume: 284
  start-page: 33161
  year: 2009
  end-page: 8
  ident: CR56
  article-title: Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.020925
– volume: 8
  start-page: S62
  year: 2002
  end-page: 7
  ident: CR3
  article-title: HIF-1 and tumor progression: pathophysiology and therapeutics
  publication-title: Trends Mol Med
  doi: 10.1016/S1471-4914(02)02317-1
– volume: 8
  start-page: 2756
  year: 2009
  end-page: 68
  ident: CR59
  article-title: MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.17.9387
– volume: 461
  start-page: 307
  year: 2011
  end-page: 15
  ident: CR4
  article-title: Invited review: decoding the microRNA response to hypoxia
  publication-title: Pflugers Arch
  doi: 10.1007/s00424-010-0910-5
– volume: 270
  start-page: 4515
  year: 2003
  end-page: 22
  ident: CR32
  article-title: Oxygen tension regulates the expression of a group of procollagen hydroxylases
  publication-title: Eur J Biochem
  doi: 10.1046/j.1432-1033.2003.03846.x
– volume: 8
  start-page: 64
  year: 2010
  ident: CR10
  article-title: The VHL-dependent regulation of microRNAs in renal cancer
  publication-title: BMC Med
  doi: 10.1186/1741-7015-8-64
– volume: 16
  start-page: 230
  year: 2010
  end-page: 7
  ident: CR14
  article-title: MiR-210 — micromanager of the hypoxia pathway
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2010.03.004
– volume: 318
  start-page: 944
  year: 2012
  end-page: 54
  ident: CR65
  article-title: Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2012.02.010
– volume: 54
  start-page: 2064
  year: 2011
  end-page: 75
  ident: CR60
  article-title: Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.24614
– volume: 284
  start-page: 35134
  year: 2009
  end-page: 43
  ident: CR51
  article-title: An integrated approach for experimental target identification of hypoxia-induced miR-210
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.052779
– volume: 29
  start-page: 4362
  year: 2010
  end-page: 8
  ident: CR53
  article-title: Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression
  publication-title: Oncogene
  doi: 10.1038/onc.2010.193
– volume: 72
  start-page: 4629
  year: 2012
  end-page: 41
  ident: CR1
  article-title: Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-1383
– volume: 26
  start-page: 228
  year: 2010
  end-page: 34
  ident: CR17
  article-title: A personalized microRNA microarray normalization method using a logistic regression model
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp655
– volume: 9
  start-page: 512
  year: 2009
  end-page: 24
  ident: CR24
  article-title: Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2009.05.005
– volume: 217
  start-page: 809
  year: 2008
  end-page: 18
  ident: CR43
  article-title: The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.21558
– volume: 10
  start-page: 273
  year: 2009
  end-page: 84
  ident: CR50
  article-title: MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2009.08.015
– volume: 27
  start-page: 1859
  year: 2007
  end-page: 67
  ident: CR22
  article-title: A microRNA signature of hypoxia
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01395-06
– volume: 10
  start-page: 295
  year: 2008
  end-page: 305
  ident: CR23
  article-title: Direct regulation of TWIST by HIF-1alpha promotes metastasis
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1691
– volume: 107
  start-page: 6334
  year: 2010
  end-page: 9
  ident: CR38
  article-title: P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0911082107
– volume: 283
  start-page: 15878
  year: 2008
  end-page: 83
  ident: CR46
  article-title: MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M800731200
– volume: 224
  start-page: 242
  year: 2010
  end-page: 9
  ident: CR47
  article-title: miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells
  publication-title: J Cell Physiol
– volume: 71
  start-page: 4640
  year: 2011
  end-page: 52
  ident: CR9
  article-title: HIF induces human embryonic stem cell markers in cancer cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-3320
– volume: 282
  start-page: 2130
  year: 2007
  end-page: 4
  ident: CR21
  article-title: Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors
  publication-title: J Biol Chem
  doi: 10.1074/jbc.C600252200
– volume: 24
  start-page: 565
  year: 2005
  end-page: 74
  ident: CR64
  article-title: Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells
  publication-title: J Exp Clin Cancer Res
– volume: 68
  start-page: 5540
  year: 2008
  end-page: 5
  ident: CR35
  article-title: Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6460
– volume: 22
  start-page: 1178
  year: 2007
  end-page: 82
  ident: CR62
  article-title: Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2007.04997.x
– volume: 5
  start-page: e10345
  year: 2010
  ident: CR52
  article-title: MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010345
– volume: 31
  start-page: 4087
  year: 2011
  end-page: 96
  ident: CR6
  article-title: MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01276-10
– volume: 10
  start-page: 858
  year: 2004
  end-page: 64
  ident: CR44
  article-title: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
  publication-title: Nat Med
  doi: 10.1038/nm1075
– volume: 358
  start-page: 2039
  year: 2008
  end-page: 49
  ident: CR41
  article-title: Tumor angiogenesis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra0706596
– volume: 16
  start-page: 1889
  year: 2012
  end-page: 99
  ident: CR25
  article-title: Hypoxia-inducible factor 1-mediated human GATA1 induction promotes erythroid differentiation under hypoxic conditions
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2011.01484.x
– volume: 104
  start-page: 879
  year: 2009
  end-page: 86
  ident: CR36
  article-title: Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.108.193102
– volume: 35
  start-page: 856
  year: 2009
  end-page: 67
  ident: CR5
  article-title: Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2009.09.006
– volume: 6
  start-page: 389
  year: 2000
  end-page: 95
  ident: CR39
  article-title: Mechanisms of angiogenesis and arteriogenesis
  publication-title: Nat Med
  doi: 10.1038/74651
– volume: 87
  start-page: 431
  year: 2010
  end-page: 9
  ident: CR57
  article-title: Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvq082
– volume: 70
  start-page: 2675
  year: 2010
  end-page: 85
  ident: CR37
  article-title: MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-2448
– volume: 284
  start-page: 33161
  year: 2009
  ident: BFaps2012195_CR56
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.020925
– volume: 381
  start-page: 335
  year: 2004
  ident: BFaps2012195_CR2
  publication-title: Methods Enzymol
  doi: 10.1016/S0076-6879(04)81023-1
– volume: 9
  start-page: 512
  year: 2009
  ident: BFaps2012195_CR24
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2009.05.005
– volume: 72
  start-page: 4629
  year: 2012
  ident: BFaps2012195_CR1
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-1383
– volume: 107
  start-page: 6334
  year: 2010
  ident: BFaps2012195_CR38
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0911082107
– volume: 16
  start-page: 4604
  year: 1996
  ident: BFaps2012195_CR42
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.16.9.4604
– volume: 11
  start-page: 407
  year: 2007
  ident: BFaps2012195_CR49
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.04.001
– volume: 8
  start-page: S62
  year: 2002
  ident: BFaps2012195_CR3
  publication-title: Trends Mol Med
  doi: 10.1016/S1471-4914(02)02317-1
– volume: 26
  start-page: 228
  year: 2010
  ident: BFaps2012195_CR17
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp655
– volume: 28
  start-page: 341
  year: 2010
  ident: BFaps2012195_CR28
  publication-title: Nature Biotechnol
  doi: 10.1038/nbt.1618
– volume: 286
  start-page: 43475
  year: 2011
  ident: BFaps2012195_CR8
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.284158
– volume: 358
  start-page: 2039
  year: 2008
  ident: BFaps2012195_CR41
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra0706596
– volume: 461
  start-page: 307
  year: 2011
  ident: BFaps2012195_CR4
  publication-title: Pflugers Arch
  doi: 10.1007/s00424-010-0910-5
– volume: 71
  start-page: 4720
  year: 2011
  ident: BFaps2012195_CR30
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-0365
– volume: 70
  start-page: 2675
  year: 2010
  ident: BFaps2012195_CR37
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-2448
– volume: 71
  start-page: 4640
  year: 2011
  ident: BFaps2012195_CR9
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-3320
– volume: 18
  start-page: 465
  year: 2011
  ident: BFaps2012195_CR55
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2010.119
– volume: 35
  start-page: 856
  year: 2009
  ident: BFaps2012195_CR5
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2009.09.006
– volume: 16
  start-page: 230
  year: 2010
  ident: BFaps2012195_CR14
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2010.03.004
– volume: 284
  start-page: 35134
  year: 2009
  ident: BFaps2012195_CR51
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.052779
– volume: 54
  start-page: 2064
  year: 2011
  ident: BFaps2012195_CR60
  publication-title: Hepatology
  doi: 10.1002/hep.24614
– volume: 286
  start-page: 2047
  year: 2011
  ident: BFaps2012195_CR12
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.158790
– volume: 28
  start-page: 2719
  year: 2009
  ident: BFaps2012195_CR29
  publication-title: EMBO J
  doi: 10.1038/emboj.2009.214
– volume: 435
  start-page: 839
  year: 2005
  ident: BFaps2012195_CR20
  publication-title: Nature
  doi: 10.1038/nature03677
– volume: 282
  start-page: 2130
  year: 2007
  ident: BFaps2012195_CR21
  publication-title: J Biol Chem
  doi: 10.1074/jbc.C600252200
– volume: 283
  start-page: 15878
  year: 2008
  ident: BFaps2012195_CR46
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M800731200
– volume: 104
  start-page: 879
  year: 2009
  ident: BFaps2012195_CR36
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.108.193102
– volume: 7
  start-page: 255
  year: 2008
  ident: BFaps2012195_CR54
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.7.2.5297
– volume: 31
  start-page: 2696
  year: 2011
  ident: BFaps2012195_CR33
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01242-10
– volume: 1
  start-page: 779
  year: 2005
  ident: BFaps2012195_CR63
  publication-title: Future Oncol
  doi: 10.2217/14796694.1.6.779
– volume: 224
  start-page: 242
  year: 2010
  ident: BFaps2012195_CR47
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.22126
– volume: 10
  start-page: 273
  year: 2009
  ident: BFaps2012195_CR50
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2009.08.015
– volume: 27
  start-page: 1859
  year: 2007
  ident: BFaps2012195_CR22
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01395-06
– volume: 10
  start-page: 295
  year: 2008
  ident: BFaps2012195_CR23
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1691
– volume: 16
  start-page: 1889
  year: 2012
  ident: BFaps2012195_CR25
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2011.01484.x
– volume: 68
  start-page: 5540
  year: 2008
  ident: BFaps2012195_CR35
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6460
– volume: 2
  start-page: 795
  year: 2002
  ident: BFaps2012195_CR40
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc909
– volume: 22
  start-page: 1178
  year: 2007
  ident: BFaps2012195_CR62
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2007.04997.x
– volume: 24
  start-page: 565
  year: 2005
  ident: BFaps2012195_CR64
  publication-title: J Exp Clin Cancer Res
– volume: 5
  start-page: e10345
  year: 2010
  ident: BFaps2012195_CR52
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010345
– volume: 217
  start-page: 809
  year: 2008
  ident: BFaps2012195_CR43
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.21558
– volume: 7
  start-page: e37537
  year: 2012
  ident: BFaps2012195_CR19
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0037537
– volume: 10
  start-page: 858
  year: 2004
  ident: BFaps2012195_CR44
  publication-title: Nat Med
  doi: 10.1038/nm1075
– volume: 31
  start-page: 4760
  year: 2011
  ident: BFaps2012195_CR31
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.05776-11
– volume: 6
  start-page: e19139
  year: 2011
  ident: BFaps2012195_CR48
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019139
– volume: 318
  start-page: 944
  year: 2012
  ident: BFaps2012195_CR65
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2012.02.010
– volume: 27
  start-page: 1506
  year: 2011
  ident: BFaps2012195_CR18
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btr180
– volume: 29
  start-page: 2638
  year: 2010
  ident: BFaps2012195_CR11
  publication-title: Oncogene
  doi: 10.1038/onc.2010.23
– volume: 31
  start-page: 4979
  year: 2012
  ident: BFaps2012195_CR26
  publication-title: Oncogene
  doi: 10.1038/onc.2011.655
– volume: 72
  start-page: 3631
  year: 2012
  ident: BFaps2012195_CR61
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-0667
– volume: 4
  start-page: e7629
  year: 2009
  ident: BFaps2012195_CR13
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0007629
– volume: 6
  start-page: e17167
  year: 2011
  ident: BFaps2012195_CR16
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0017167
– volume: 6
  start-page: 389
  year: 2000
  ident: BFaps2012195_CR39
  publication-title: Nat Med
  doi: 10.1038/74651
– volume: 31
  start-page: 4087
  year: 2011
  ident: BFaps2012195_CR6
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01276-10
– volume: 87
  start-page: 431
  year: 2010
  ident: BFaps2012195_CR57
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvq082
– volume: 9
  start-page: 1072
  year: 2010
  ident: BFaps2012195_CR15
  publication-title: Cell Cycle
  doi: 10.4161/cc.9.6.11006
– volume: 29
  start-page: 4362
  year: 2010
  ident: BFaps2012195_CR53
  publication-title: Oncogene
  doi: 10.1038/onc.2010.193
– volume: 285
  start-page: 20281
  year: 2010
  ident: BFaps2012195_CR58
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.109207
– volume: 8
  start-page: 64
  year: 2010
  ident: BFaps2012195_CR10
  publication-title: BMC Med
  doi: 10.1186/1741-7015-8-64
– volume: 69
  start-page: 1221
  year: 2009
  ident: BFaps2012195_CR7
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-2516
– volume: 120
  start-page: 4141
  year: 2010
  ident: BFaps2012195_CR34
  publication-title: J Clin Invest
  doi: 10.1172/JCI42980
– volume: 12
  start-page: 210
  year: 2010
  ident: BFaps2012195_CR27
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr2720
– volume: 270
  start-page: 4515
  year: 2003
  ident: BFaps2012195_CR32
  publication-title: Eur J Biochem
  doi: 10.1046/j.1432-1033.2003.03846.x
– volume: 8
  start-page: 2756
  year: 2009
  ident: BFaps2012195_CR59
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.17.9387
– volume: 93
  start-page: 1074
  year: 2003
  ident: BFaps2012195_CR45
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000102937.50486.1B
– reference: 22286762 - Oncogene. 2012 Nov 29;31(48):4979-86
– reference: 16556057 - Future Oncol. 2005 Dec;1(6):779-86
– reference: 19893619 - PLoS One. 2009;4(10):e7629
– reference: 18720385 - J Cell Physiol. 2008 Dec;217(3):809-18
– reference: 18059191 - Cancer Biol Ther. 2008 Feb;7(2):255-64
– reference: 19490906 - Cell Metab. 2009 Jun;9(6):512-24
– reference: 18297062 - Nat Cell Biol. 2008 Mar;10(3):295-305
– reference: 22962263 - Cancer Res. 2012 Sep 15;72(18):4629-41
– reference: 15944709 - Nature. 2005 Jun 9;435(7043):839-43
– reference: 19933824 - Bioinformatics. 2010 Jan 15;26(2):228-34
– reference: 20351690 - Nat Biotechnol. 2010 Apr;28(4):341-7
– reference: 20498629 - Oncogene. 2010 Jul 29;29(30):4362-8
– reference: 21555452 - Mol Cell Biol. 2011 Jul;31(13):2696-706
– reference: 22020939 - J Biol Chem. 2011 Dec 16;286(50):43475-85
– reference: 19721136 - J Biol Chem. 2009 Nov 27;284(48):33161-8
– reference: 18463380 - N Engl J Med. 2008 May 8;358(19):2039-49
– reference: 22655055 - PLoS One. 2012;7(5):e37537
– reference: 21347261 - PLoS One. 2011;6(2):e17167
– reference: 20885442 - Cell Death Differ. 2011 Mar;18(3):465-78
– reference: 17482131 - Cancer Cell. 2007 May;11(5):407-20
– reference: 21969601 - Mol Cell Biol. 2011 Dec;31(23):4760-74
– reference: 8756616 - Mol Cell Biol. 1996 Sep;16(9):4604-13
– reference: 20308559 - Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9
– reference: 22387901 - Exp Cell Res. 2012 May 1;318(8):944-54
– reference: 10742145 - Nat Med. 2000 Apr;6(4):389-95
– reference: 17135268 - J Biol Chem. 2007 Jan 26;282(4):2130-4
– reference: 18417479 - J Biol Chem. 2008 Jun 6;283(23):15878-83
– reference: 20972335 - J Clin Invest. 2010 Nov;120(11):4141-54
– reference: 17559361 - J Gastroenterol Hepatol. 2007 Aug;22(8):1178-82
– reference: 20436681 - PLoS One. 2010;5(4):e10345
– reference: 21207057 - Pflugers Arch. 2011 Mar;461(3):307-15
– reference: 19265035 - Circ Res. 2009 Apr 10;104(7):879-86
– reference: 20404348 - J Biol Chem. 2010 Jun 25;285(26):20281-90
– reference: 20964835 - BMC Med. 2010;8:64
– reference: 21555366 - Cancer Res. 2011 Jul 1;71(13):4720-31
– reference: 19652553 - Cell Cycle. 2009 Sep 1;8(17):2756-68
– reference: 20219857 - Cardiovasc Res. 2010 Aug 1;87(3):431-9
– reference: 15063685 - Methods Enzymol. 2004;381:335-54
– reference: 19696742 - EMBO J. 2009 Sep 16;28(18):2719-32
– reference: 22050843 - J Cell Mol Med. 2012 Aug;16(8):1889-99
– reference: 20237418 - Cell Cycle. 2010 Mar 15;9(6):1072-83
– reference: 18632605 - Cancer Res. 2008 Jul 15;68(14):5540-5
– reference: 20233879 - Cancer Res. 2010 Apr 1;70(7):2675-85
– reference: 20232316 - J Cell Physiol. 2010 Jul;224(1):242-9
– reference: 14576200 - Circ Res. 2003 Nov 28;93(11):1074-81
– reference: 14622280 - Eur J Biochem. 2003 Nov;270(22):4515-22
– reference: 19808020 - Cell Metab. 2009 Oct;10(4):273-84
– reference: 15235597 - Nat Med. 2004 Aug;10(8):858-64
– reference: 12360282 - Nat Rev Cancer. 2002 Oct;2(10):795-803
– reference: 16471319 - J Exp Clin Cancer Res. 2005 Dec;24(4):565-74
– reference: 21067538 - Breast Cancer Res. 2010;12(5):210
– reference: 20154725 - Oncogene. 2010 May 6;29(18):2638-48
– reference: 21081489 - J Biol Chem. 2011 Jan 21;286(3):2047-56
– reference: 22144109 - Hepatology. 2011 Dec;54(6):2064-75
– reference: 22593189 - Cancer Res. 2012 Jul 15;72(14):3631-41
– reference: 21544242 - PLoS One. 2011;6(4):e19139
– reference: 20434954 - Trends Mol Med. 2010 May;16(5):230-7
– reference: 19782034 - Mol Cell. 2009 Sep 24;35(6):856-67
– reference: 17194750 - Mol Cell Biol. 2007 Mar;27(5):1859-67
– reference: 21498399 - Bioinformatics. 2011 Jun 1;27(11):1506-12
– reference: 19141645 - Cancer Res. 2009 Feb 1;69(3):1221-9
– reference: 21712410 - Cancer Res. 2011 Jul 1;71(13):4640-52
– reference: 11927290 - Trends Mol Med. 2002;8(4 Suppl):S62-7
– reference: 21807897 - Mol Cell Biol. 2011 Oct;31(19):4087-96
– reference: 19826008 - J Biol Chem. 2009 Dec 11;284(50):35134-43
SSID ssj0032319
Score 2.3969178
SecondaryResourceType review_article
Snippet Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by...
Hypoxia plays an important role in the tumor microenvironment by allowing the development and maintenance of cancer cells, but the regulatory mechanisms by...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 336
SubjectTerms Biomedical and Life Sciences
Biomedicine
Cell Hypoxia - genetics
Gene Expression Regulation
Humans
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Immunology
Internal Medicine
Medical Microbiology
microRNA
MicroRNAs - genetics
Neoplasms - blood supply
Neoplasms - genetics
Neoplasms - metabolism
Neovascularization, Pathologic - genetics
Pharmacology/Toxicology
Review
Up-Regulation
Vaccine
人类
小分子RNA
癌症
细胞周期调控
缺氧条件
缺氧诱导因子1
肿瘤细胞
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BOcAF8d2UUhkJ9tKGOrETOydUVVQrJKoKtdLeLMdxYKWS3e5uJfbfM-N8LEsrznYcyzO2nz3j9wA-OK9szVUae0dPcjKv4rLwPhYIlWtE6L4OoZhv5_n4Sn6dZJPuwm3ZpVX2a2JYqKuZozvy40SQpqzC_frz_CYm1SiKrnYSGg_hUaAuQ39Wk-HAJRC7EPxNckXnJC26xHcu9LGdE1d3kn5KSFniMS41zY8b3Cy2t6c7mPNu6uQ_8dOwLZ09g6cdnmQnrQM8hwe-eQGji5aQen3ELjfvq5ZHbMQuNlTV65dwOF7PZ7-nNl60kvS-Yr8oQ-_7-cmSTRsWFPyYI89YvIKrsy-Xp-O4k0-IXSbTVYyT1dY6daLmlVO5T4lJBg90UlurdOGl9Rzhmcxrj7O6lnle1CoprRYll6WrxWvYaWaN3wVWOPwmqXiFTUnuZYmgx4vKZrrkzlU8gr1hBM28pckwMhOyUAUWHvZDalxHPE76F9cmBMCFNmgMQ8YwaIwIPg61-5bur7ffW8d0025pNk4SwfuhGCcMRUFs42e3bR1d4DFORfCmNebwo1QIYgTUEagtMw8ViIx7u6SZ_gyk3CLTCqF2BKPeIf7q1j393_t__9_CkzQIb1C22z7srBa3_h3Cn1V5EHz8D-m7A3U
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fT9swED4xeNnLtME2wthkpK0vNODETuw8ogpUIYHQBBJvluPYUImlXVuk9b_f2fnBOnjg2RfH8t3Z3-nO3wF8N1ZoR0UaW-Of5GRWxGVhbcwQKjtE6NaFVMzFZT6-4ee32e0GDLu3MKFoP1BahmO6qw471jPPrZ2kR0mRvYEtiRGdt-dRPurOXYZIxYPdJBc-KpKsLXOnTK597UkU7qf13W-8GtYvo2cI83mh5H_Z0nAJnb2Hdy16JCfNej_Ahq23YXDV0E-vhuT66TXVYkgG5OqJmHq1A4fj1Wz6Z6LjedOA3lbkl6_H-3l5siCTmoR-fcR4O5h_hJuz0-vROG6bJcQm4-kyRtfUTqaGOVoZkdvU88Zg-Mal1kIWlmtLEYzx3Fn0YcfzvHAiKbVkJeWlcewTbNbT2u4CKQx-k1S0wqk4tbxEiGNZpTNZUmMqGsFev4Nq1pBiKJ4xXogCBw-7LVWmpRn33S4eVEh3M6lQGcorQ6EyIvjRS3czvSy332lHtU62UAnzbYYFQrgIDvphdA-f89C1nT42MrLAoE1E8LlRZv-jlDHP_ycjEGtq7gU89fb6SD25DxTcLJMCgXUEg84g_lnWC-vfe63gF3ibhoYbvsptHzaX80f7FWHPsvwWrP0vn5f_bg
  priority: 102
  providerName: Springer Nature
Title Hypoxia-regulated microRNAs in human cancer
URI http://lib.cqvip.com/qk/95561A/201303/45349790.html
https://link.springer.com/article/10.1038/aps.2012.195
https://www.ncbi.nlm.nih.gov/pubmed/23377548
https://www.proquest.com/docview/1314517056
https://www.proquest.com/docview/1314892607
https://pubmed.ncbi.nlm.nih.gov/PMC3587916
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9swFD708rKXsa67uOuCC1teWne2JVvSwxhJaAiDhlAayJuQZXkNdE6apND8-x751qbNQ58MlmQLHR3OdzjS9wH80IapzGehZ7S9khMZ5iXCGI8gVM4QoZusKMVcDuPBmP6dRJMdqNVGqwVcbk3trJ7UeHF7_nC3_oMO_7u8Ms5_qbnl3Q7C80BEu7CPMSm2adglbeoJBFGMKK9GWvHWiFZH4F-OtgQLN7P83x2Gjc1A9Qp9vj5E-aKSWgSo_gd4XyFLt1NuhQPYMflHaI9Kaur1mXv9dNNqeea23dETafX6EE4H6_nsYaq8RSlOb1L3vz2rdzXsLN1p7hZafq62e2TxCcb9i-vewKuEFDwd0XDloduqjIeaZH6qWWxCyymDqR3lSjEuDFXGR6BG48ygf2c0jkXGgkRxkvg00Rn5DHv5LDdfwRUaxwSpn-KnqG9ogvDHkFRFPPG1Tn0HjpoVlPOSMEPSiFDBBDae1ksqdUVBbpUwbmVRCidcojGkNYZEYzjws-ldf2l7v-PaOrLePzIgVoKYIbxz4KRpRtex9RCVm9l92YcLTOiYA19KYzY_Cgmx3IDcAbZh5qaDpeXebMmnNwU9N4k4Q9DtQLveEM-mtWX-R2-Y4Dd4FxY6HPbw2zHsrRb35juioVXSgl02YS3Y7_S73SE-uxfD0RW-7cW9VuEEj1XLDNM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fT9swED6x8sBepv1eGNsyafQFMpLYiZ2HaWIbqAyoKlQk3ozjOKwSpKUt2vpP7W_cXX6060B749muY_nO9ufe3fcBfDBW6NwXoWcNleREVnhpYq3HECrniNBtXoZijrtx55R_P4vOVuB3UwtDaZXNmVge1NnQ0H_kOwEjTVmB9_Xn0bVHqlEUXW0kNCq3OLSzn_hkm3w6-Ib23QzD_b3-145Xqwp4JuLh1EMf1rkMDcv9zIjYhkSwgu8cLrUWMrFcWx9RC49zi86e8zhOchGkWrLU56nJGY77AFY5VbS2YPXLXrd30pz9DNESAe4gFvQyk6xOtfeZ3NEjYgcPwo8BaVms4eFWXFzj9bR8Id5CubeTNf-J2JYX4f5jeFQjWHe3crknsGKLp9DuVRTYs223v6jommy7bbe3IMeePYOtzmw0_DXQ3thekHKYzdwrygk86e5O3EHhlpqBriFfHD-H03tZ2hfQKoaFfQVuYvA3QeZnOBT3LU8RZlmW6UimvjGZ78D6fAXVqCLmUDxiPBEJNm41S6pMTXVOihuXqgy5M6nQGIqModAYDmzOezcj3d1vo7GOqjf6RC3c0oH382bcohR30YUd3lR9ZIIPR-HAy8qY8w-FjBEHoXRALJl53oHov5dbisGPkgacRVIguHeg3TjEX9O6Y_7r_5__O1jr9I-P1NFB9_A1PAxL2Q_KtduA1nR8Y98g-Jqmb2uPd-H8vjfZH7gKQNo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIQEviG8yBhiJ9WULTWIndh4QmhhVx6Cq0Cb1zTiOPSptadd2gv5r_HWc81XKJt727Ktj-e7s3_XOvwN4qw1XNuCRb7R7khMb7mepMT5FqGwRoRtbpmK-DpL-Cfs8ikcb8Lt5C-PKKpszsTyo84l2_5F3Q-p6ynK8r7u2LosYHvQ-TC9810HKZVqbdhqViRyZ5U8M3-bvDw9Q1ztR1Pt0_LHv1x0GfB2zaOGjPSsrIk1tkGuemMiRrWDMw4RSXKSGKRMggmGJNWj4liVJanmYKUGzgGXaUpz3FtzmFFEV-hIftcEeRdzkoHeYcBejCVoX3QdUdNXU8YSH0bvQdbW4i8dccXqBF9X61XgF714t2_wnd1teib0HcL_GsmS_Mr6HsGGKR9AZVmTYyz1yvHrbNd8jHTJc0WQvH8Nufzmd_Borf2ZOXQ8xk5NzVx34bbA_J-OClN0DiXZWOXsCJzeysU9hs5gU5jmQVONvwjzIcSoWGJYh4DI0V7HIAq3zwIOtdgfltKLokCymLOUpDu42Wyp1TXruem-cyTL5ToVEZUinDInK8GCnlW5mul5uu9GOrF1-LlcG6sGbdhid1WVgVGEml5WMSDGE5B48q5TZfiii1LERCg_4mppbAUcEvj5SjH-UhOA0FhxhvgedxiD-WtY169_6__pfwx10LfnlcHD0Au5FZf8PV3S3DZuL2aV5iShskb0qzZ3A95v2rz8L2kOh
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia-regulated+microRNAs+in+human+cancer&rft.jtitle=Acta+pharmacologica+Sinica&rft.au=Shen%2C+Guomin&rft.au=Li%2C+Xiaobo&rft.au=Jia%2C+Yong-feng&rft.au=Piazza%2C+Gary+A&rft.date=2013-03-01&rft.issn=1745-7254&rft.eissn=1745-7254&rft.volume=34&rft.issue=3&rft.spage=336&rft_id=info:doi/10.1038%2Faps.2012.195&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F95561A%2F95561A.jpg